Current Report · Items 5.02, 7.01, 9.01 · 8-K
Aeternum Resources Inc.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Item 7.01 Regulation FD Disclosures. On August 4, 2026, the Company issued a press release regarding the employment of Josua Oosthuizen as CEO of the Company. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.…
Filed Sep 1, 2026Accepted Sep 1, 2026, 10:30 AM EDTCIK 764630Accession 0001493152-26-040954
Company context
Current securities
Historical securities (6)
Registered securities in this filing
AETERNUM HEALTH, INC. · 8-K · Filed 2026-09-01
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock, par value $.01
- Symbol
- AETN
- Exchange
- Not supplied
- Classification
- COMMON
Filing context
Context: AsOf2026-07-31
Dimensions: Not supplied
Accession 000149315226040954 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 5.02, 7.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item
7.01 Regulation FD Disclosures.
On
August 4, 2026, the Company issued a press release regarding the employment of Josua Oosthuizen as CEO of the Company. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
In
accordance with General Instruction B.2 of this Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1,
shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing.
Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination
by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information
is required by Regulation FD.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htmEX-99.1
4
ex99-1.htm
EX-99.1
Exhibit 99.1
Aeternum
Health Announces Change in Strategy, New Management, and Updates Investors on Progress
Aeternum
Health will change its name to Aeternum Resources and seeks to become a Strategic Supplier
of Critical Materials.
──────────────────────────────────────────────────────────────────────────────────────────────────
Appoints
Paul Mann as President and Executive Chairman and Josua Oosthuizen as Chief Executive Officer.
Raised
over $4 million in financing to accelerate the progress on a tin and niobium mine in Nigeria,
which is expected to enter commercial production during 1H 2027.
Long
lead-time items have been secured, access road constructed, geological surveys successfully
conducted and critical infrastructure installed to accelerate initial production.
CITY
- August 4, 2026 - Aeternum Health (OTC: AETN) (“Company”), today announced a change in strategy,
new management and provides investors with an update on corporate progress.
Change
in Name and Strategy
The
Company and its shareholders have decided to change the name and the strategic focus of the Company. The Company, which will now be called
Aeternum…
Open exhibit ↗